Cited by

• From standard therapies to monoclonal antibodies and immune checkpoint inhibitors - an update for reconstructive surgeons on common oncological cases.

  Knoedler L, Huelsboemer L, Hollmann K, Alfertshofer M, Herfeld K, Hosseini H, Boroumand S, Stoegner VA, Safi AF, Perl M, Knoedler S, Pomahac B, Kauke-Navarro M. Knoedler L, et al. Front Immunol. 2024 Apr 23;15:1276306. doi: 10.3389/fimmu.2024.1276306. eCollection 2024. Front Immunol. 2024. PMID: 38715609 Free PMC article. Review.
• Inflation-adjusted medicare physician reimbursement for adult spinal deformity surgery substantially declined from 2002 to 2020.

  Mo KC, Ortiz-Babilonia C, Musharbash FN, Raad M, Aponte JS, Neuman BJ, Jain A, Kebaish KM. Mo KC, et al. Spine Deform. 2024 Mar;12(2):263-270. doi: 10.1007/s43390-023-00779-7. Epub 2023 Nov 30. Spine Deform. 2024. PMID: 38036867 Review.
• Black-white inequities in melanoma surgical outcomes and interventions: an epidemiologic multivariate analysis utilizing the National Cancer Database.

  Abdelwahab RM, Liszewski W, Vidal NY, Demer A. Abdelwahab RM, et al. Arch Dermatol Res. 2023 Nov 28;316(1):7. doi: 10.1007/s00403-023-02770-8. Arch Dermatol Res. 2023. PMID: 38015247 No abstract available.
• Multimodal Metabolic Imaging Reveals Pigment Reduction and Lipid Accumulation in Metastatic Melanoma.

  Lee HJ, Chen Z, Collard M, Chen F, Chen JG, Wu M, Alani RM, Cheng JX. Lee HJ, et al. BME Front. 2021 Oct 8;2021:9860123. doi: 10.34133/2021/9860123. eCollection 2021. BME Front. 2021. PMID: 37849907 Free PMC article.
• TRPM2 Channels: A Potential Therapeutic Target in Melanoma?

  Foster HM, Carle MN, Jira LR, Koh DW. Foster HM, et al. Int J Mol Sci. 2023 Jun 21;24(13):10437. doi: 10.3390/ijms241310437. Int J Mol Sci. 2023. PMID: 37445615 Free PMC article. Review.